How do sugar units change during illness?

Jan 05, 2026

Leave a message

Isabella Thomas
Isabella Thomas
Isabella is a procurement specialist at Hangzhou Leap Chem Co., Ltd. She is responsible for sourcing high - quality raw materials for the production of chemical products, ensuring the stability of the supply chain.

Sugar units play a fundamental role in the human body, serving as a primary source of energy and participating in numerous biochemical processes. During illness, the body undergoes a series of physiological changes that can significantly impact the metabolism and utilization of sugar units. As a sugar units supplier, I have witnessed firsthand the importance of understanding these changes to provide appropriate products and support for patients and the medical community. In this blog, I will explore how sugar units change during illness and discuss the implications for our supply and the healthcare industry.

1. Normal Sugar Unit Metabolism

Before delving into the changes during illness, it is essential to understand the normal metabolism of sugar units in the body. The most common sugar unit is glucose, which is absorbed from the digestive tract into the bloodstream after the breakdown of carbohydrates in food. Glucose is then transported to cells throughout the body, where it is used for energy production through a process called glycolysis. In addition to glucose, other sugar units such as fructose and galactose are also absorbed and metabolized, although they follow slightly different pathways.

The body tightly regulates blood glucose levels to ensure a constant supply of energy to cells. The pancreas plays a crucial role in this regulation by secreting insulin and glucagon. Insulin promotes the uptake of glucose by cells and the storage of excess glucose as glycogen in the liver and muscles. Glucagon, on the other hand, stimulates the breakdown of glycogen into glucose and the release of glucose into the bloodstream when blood glucose levels are low.

2. Changes in Sugar Unit Metabolism during Illness

Illness can disrupt the normal metabolism of sugar units in several ways. One of the most common changes is an increase in blood glucose levels, known as hyperglycemia. This can occur due to a variety of factors, including stress, inflammation, and the release of counter - regulatory hormones such as cortisol and epinephrine.

2.1 Stress and Inflammation

When the body is under stress or experiencing inflammation, the immune system is activated, and the body releases cytokines and other inflammatory mediators. These substances can interfere with insulin signaling and reduce the uptake of glucose by cells. As a result, blood glucose levels rise. For example, in patients with severe infections or trauma, the body's stress response can lead to significant hyperglycemia, even in individuals without pre - existing diabetes.

2.2 Hormonal Changes

During illness, the body also releases counter - regulatory hormones such as cortisol, epinephrine, and glucagon. Cortisol, often referred to as the "stress hormone," increases blood glucose levels by promoting gluconeogenesis (the production of glucose from non - carbohydrate sources such as amino acids and glycerol) in the liver and reducing insulin sensitivity in peripheral tissues. Epinephrine and glucagon also stimulate glycogenolysis (the breakdown of glycogen into glucose) and gluconeogenesis, further contributing to hyperglycemia.

2.3 Altered Nutritional Intake

Illness can also affect a patient's nutritional intake. In some cases, patients may have a reduced appetite or difficulty eating, leading to decreased carbohydrate intake. However, in other situations, such as in patients receiving parenteral nutrition or tube feeding, the amount and type of carbohydrates provided can be a significant factor in blood glucose regulation. If the carbohydrate load is too high or not properly adjusted, it can contribute to hyperglycemia.

3. Specific Illnesses and Sugar Unit Changes

3.1 Diabetes - Related Illnesses

In patients with diabetes, illness can have a particularly profound impact on blood glucose levels. Diabetes is a chronic condition characterized by impaired insulin secretion or action, resulting in elevated blood glucose levels. During illness, the stress response and hormonal changes can further exacerbate hyperglycemia, increasing the risk of diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS). These conditions are life - threatening and require immediate medical attention.

3.2 Infectious Diseases

Infectious diseases, such as pneumonia, urinary tract infections, and sepsis, can also cause significant changes in sugar unit metabolism. The body's immune response to the infection leads to inflammation and the release of cytokines, which can interfere with insulin action. Additionally, the use of certain medications, such as corticosteroids, to treat the infection can further contribute to hyperglycemia.

2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate丨CAS 122111-01-7L(+)-Arabinose丨CAS 87-72-9

3.3 Cancer

Cancer patients often experience metabolic changes, including alterations in sugar unit metabolism. Tumor cells have a high demand for energy and nutrients, and they can consume large amounts of glucose. This can lead to increased blood glucose levels in some patients, especially those with advanced cancer. Moreover, cancer treatments such as chemotherapy and radiotherapy can also affect the normal function of the pancreas and other organs involved in glucose regulation, further complicating sugar unit metabolism.

4. Implications for Sugar Unit Supply

As a sugar units supplier, these changes in sugar unit metabolism during illness have several implications for our business. First, there is an increased demand for products that can help manage blood glucose levels. For example, we offer a range of sugar units that can be used in the formulation of specialized diets for patients with diabetes or other metabolic disorders. Our products such as 2 - Deoxy - 2,2 - difluoro - D - erythro - pentafuranous - 1 - ulose - 3,5 - dibenzoate丨CAS 122111 - 01 - 7 and L-(+)-Gulono - 1,4 - lactone丨CAS 1128 - 23 - 0 have unique properties that can be beneficial in certain medical applications.

Second, we need to ensure the quality and safety of our products. During illness, patients are often more vulnerable, and any impurities or contaminants in the sugar units can have serious consequences. We adhere to strict quality control standards to guarantee that our products meet the highest quality requirements.

Finally, we need to work closely with the medical community to understand the specific needs of patients during illness. By collaborating with healthcare providers, researchers, and pharmaceutical companies, we can develop new products and solutions that are tailored to the changing sugar unit metabolism in different disease states.

5. Products for Specialized Needs

We offer a diverse range of sugar units that can be used in various medical applications. L(+)-Arabinose丨CAS 87 - 72 - 9 is one such product. It has been shown to have potential benefits in regulating blood glucose levels and improving insulin sensitivity. It can be incorporated into functional foods or dietary supplements for patients with diabetes or those at risk of developing metabolic disorders.

Our 2 - Deoxy - 2,2 - difluoro - D - erythro - pentafuranous - 1 - ulose - 3,5 - dibenzoate is used in the synthesis of certain antiviral and anticancer drugs. Its unique chemical structure makes it a valuable building block in pharmaceutical research and development. L-(+)-Gulono - 1,4 - lactone is an important intermediate in the synthesis of vitamin C and has antioxidant properties, which can be beneficial for patients with oxidative stress associated with illness.

6. Conclusion and Call to Action

Understanding how sugar units change during illness is crucial for both the healthcare industry and our business as a sugar units supplier. The changes in sugar unit metabolism during illness present challenges but also opportunities for innovation and collaboration. We are committed to providing high - quality sugar units that can meet the diverse needs of patients and the medical community.

If you are interested in learning more about our sugar unit products or discussing potential procurement opportunities, we encourage you to reach out to us. Our team of experts is ready to assist you in finding the right solutions for your specific requirements. Whether you are a healthcare provider looking for specialized dietary products or a pharmaceutical company in need of high - quality sugar unit building blocks, we can work together to address the challenges posed by changes in sugar unit metabolism during illness.

References

  1. American Diabetes Association. Standards of Medical Care in Diabetes - 2023. Diabetes Care. 2023;46(Suppl 1):S1 - S236.
  2. Riddle MC, Davidson JA, Ziemen M, et al. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022;45(12):2622 - 2645.
  3. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359 - 1367.
Send Inquiry
Beyond Your Expectation
From Science to Life with LEAPChem
contact us